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peptide corresponding to its single transmembrane domain (TMD) was reconstituted into mammalian raft model membranes
composed of an unsaturated glycerophospholipid, sphingomyelin, and cholesterol. The peptide membrane lateral organization
and dynamics, and its influence on membrane properties, were studied by steady-state and time-resolved fluorescence tech-
niques and by attenuated total reflection Fourier transformed infrared spectroscopy. Our results show that Fas TMD is prefer-
entially localized in liquid-disordered membrane regions and undergoes a strong reorganization as the membrane composition is
changed toward the liquid-ordered phase. This results from the strong hydrophobic mismatch between the length of the peptide
hydrophobic stretch and the hydrophobic thickness of liquid-ordered membranes. The stability of nonclustered Fas TMD in
liquid-disordered domains suggests that its sequence may have a protective function against nonligand-induced Fas clustering
in lipid rafts. It has been reported that ceramide induces Fas oligomerization in lipid rafts. Here, it is shown that neither Fas TMD
membrane organization nor its conformation is affected by ceramide. These results are discussed within the framework of Fas
membrane signaling events.INTRODUCTIONFas (CD95/Apo1), a member of the tumor necrosis factor
receptor superfamily, is one of the most studied death recep-
tors (1,2). Together with its ligand, FasL, it constitutes one
of the major regulators of cell death and survival in mamma-
lian cells (3). Fas is a 45-kDa type I transmembrane glyco-
protein with an N-terminal cysteine-rich extracellular
domain (binding domain) and a C-terminal charged cyto-
plasmatic domain containing an 80-amino-acid region
called the death domain that is essential to initiate apoptosis
(4). After binding to FasL, preassembled Fas trimers cluster
with the Fas-associated death-domain protein (FADD)
through their death domains (3,4). Fas-bound FADD associ-
ates with procaspase-8, procaspase-10, and the caspase
regulator c-FLIP via its death effector domain, forming a
protein oligomer called death-inducing signaling complex
(DISC) (2). This oligomerization process results in the
release of active caspase-8, initiating apoptotic signaling.
In the last few years, lipid rafts have emerged as impor-
tant mediators of Fas clustering (5–8). Lipid rafts are dy-
namic membrane regions enriched in cholesterol (Chol)
and sphingolipids (9) that, due to their high content in satu-
rated sphingolipids and their tight interactions with Chol,
are believed to have properties similar to those of the
liquid-ordered (lo) phase (10). Lipid rafts have been in-
volved in several biological processes, ranging from mem-
brane trafficking and organization to signal transduction
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0006-3495/11/10/1632/10 $2.00binding, a process that is vital for efficient DISC formation
and apoptosis triggering (6,7,11). This observation was sus-
tained by the finding that blocking Fas localization to lipid
rafts obstructs its aggregation with intracellular apoptotic
proteins, inhibiting apoptosis (5,12,13). It has been reported
that Fas oligomerization in lipid rafts is facilitated by the
formation of ceramide (Cer) (14,15). After binding to
FasL or agonistic molecules, Fas translocation to lipid rafts
results in the formation of Cer in those domains by the
action of acid sphingomyelinase (14,15). As a result, small
rafts coalesce into large signaling platforms where Fas olig-
omerization and DISC formation is enhanced, triggering an
efficient apoptosis signal. Ceramide is the simplest sphingo-
lipid and an established active participant in several biolog-
ical processes, for example, cell signaling (16). Alterations
in membrane biophysical properties caused by Cer seem to
be the basis of its biological functions (17). Studies in model
membranes have shown that Cer has a strong tendency to
form highly ordered gel phases, in a process that is highly
dependent on membrane composition (18–20). Cer modifies
lipid-raft biophysical properties (21–24), affecting the sort-
ing of molecules into/out of these membrane domains (25).
However, the role of Cer in signaling, namely in apoptosis
triggering, is still not fully understood.
To better understand which biophysical mechanisms may
govern Fas translocation and clustering in lipid rafts and
how Cer is able to modulate these processes, we selected
the transmembrane domain (TMD) of human Fas receptor
and studied its membrane organization in the model raft
system POPC/PSM/Chol (26) in the absence and presence
of Cer. Taking advantage of Fas TMD intrinsic fluorescencedoi: 10.1016/j.bpj.2011.08.022
Fas Transmembrane Domain Organization 1633due to the presence of two tryptophan residues (Trp176 and
Trp189), steady- and transient-state fluorescence techniques,
together with attenuated total reflection Fourier transformed
infrared spectroscopy (ATR-FTIR), allowed us to study the
peptide lateral distribution, membrane localization, and
dynamics in nonraft and raftlike membranes and also to
assess Cer effects on those properties. Our results show that
Fas TMD conformation and sorting are highly dependent
on the membrane state. The peptide presents a strong prefer-
ence for nonraft membranes (i.e., the liquid-disordered (ld)
phase), which persists in the presence of Cer. The biological
implications in terms of receptor translocation and clustering
to lipid rafts and apoptosis induction are discussed.MATERIALS AND METHODS
Materials
A peptide with the sequence n-Ser-Asn-Leu-Gly-Trp-Leu-Cys-Leu-Leu-
Leu-Leu-Pro-Ile-Pro-Leu-Ileu-Val-Trp-Val-Lys-Arg-C corresponding to
the TMD of Fas (TNFRSF6) (see Supporting Material for further details)
was purchased from AnaSpec (Freemont, CA). The peptide was deemed
to be >95% pure, as determined by analytical high-performance liquid
chromatography and mass spectrometry, and was kept lyophilized at
20C until use. The lipids and probes 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC), N-palmitoyl-sphingomyelin (PSM), and palmi-
toyl ceramide (PCer) were obtained from Avanti Polar Lipids (Alabaster,
AL). Cholesterol (Chol) was from Sigma (St. Louis, MO). Tris-(2-cya-
noethyl)-phosphine (TCEP) was purchased from Molecular Probes (Lei-
den, The Netherlands). All organic solvents were UVASOL grade from
Merck (Darmstadt, Germany).Liposome preparation
Multilamellar vesicles (MLVs) with or without peptide and PCer and
composed of POPC/PSM/Chol mixtures that are contained within the tie
line that spans the 1:1:1 composition in the POPC/PSM/Chol phase diagram
(26) (Fig. S1 in the Supporting Material) were prepared as described previ-
ously (23,27). The lipids were suspended in buffer (20 mMHEPES, 10 mM
NaCl, 0.1 mM EDTA, 1 mM TCEP, pH 7.4). Addition of the reducing agent
TCEP in the suspension buffer was used to prevent peptide dimerization
through persulfide bond formation between Cys residues. The total lipid
concentration was 0.6 mM and the peptide concentration was varied
between 0.35%, 0.7%, and 3.0% total lipid.
The concentration of lipid and probes in stock solutionswas determined as
previously described (23). Fas peptide concentration was determined spec-
trophotometrically using ε(Fas, 280 nm, propanol)¼ 12,150M1 cm1 (28).Absorption and fluorescence
Absorption and steady-state fluorescence measurements were performed
as described previously (29). Steady-state fluorescence anisotropy was
calculated using
hri ¼ ðIVV  G  IVHÞðIVV þ 2  G  IVHÞ; (1)
in which the different intensities (blank subtracted) are the steady-state
vertical and horizontal components of the fluorescence emission with
excitation vertical (IVV and IVH, respectively), and G is the instrumental
correction factor. The excitation (lexc)/emission (lem) wavelengths were295 nm/340 nm for steady-state anisotropy (hri) and 280 nm/340 nm for
emission and excitation spectra.
Trp fluorescence decays (excitation at l¼ 295 nm) were measured at l¼
340 nm using the magic angle (54.7) relative to the vertically polarized
excitation beam produced by a frequency doubled Rhodamine 6G laser,
as previously described (26,27). The data were analyzed with the TRFA
software (Scientific Software Technologies Center, Minsk, Belarus). For
a decay described by a sum of exponentials where ai is the normalized pre-
exponential and ti is the lifetime of decay component i, the quantum-yield-





The time-resolved fluorescence anisotropies were determined as de-










where i is the number of components in the anisotropy decay (in this study,
i¼ 1 in the lo phase and i¼ 2 in the ld phase membranes), rN is the residual
anisotropy, bi is the amplitude of component i, and qi is the rotational corre-
lation time of the component i. The fundamental anisotropy (r0) is given byP
ibi þ rN. The ti values obtained from the magic-angle decay were fixed
during the analysis. The goodness of the fit was judged from the reduced c2
values, the random distribution of the weighted residuals, and the corre-
spondence between the experimental steady-state value of anisotropy and
the integrated anisotropy decay.Infrared spectroscopy
Details about sample preparation and instrumentation for ATR-FTIR are
described in the Supporting Material.Determination of Fas TMD phase behavior
The partition coefficient of Fas TMD between the lo and ld phases, K
lo=ld
p , in
POPC/PSM/Chol ternary mixtures was determined from the variation of the
peptide’s photophysical parameters with the molar fraction of the lo phase
(Xlo). The molar fraction of each phase (Xi) was obtained from the tie line of
the respective phase diagram (Fig. S1) (26), employing the lever rule. The
partition coefficient (Kp) is an equilibrium constant that quantifies peptide
distribution between the two phases present in the ternary mixtures (lo
and ld). Kp was calculated from the Fas TMD quantum-yield-weighted
lifetime according to (23)
t ¼ tloKpXlo þ tldXld
KpXlo þ Xld ; (4)
where Xi is the phase mole fraction and ti is the quantum-yield-weighted
lifetime of Fas TMD in phase i. Kp is obtained by fitting the previous
equation to the experimental data as a function of Xi.RESULTS
Fas TMD steady-state fluorescence
The fluorescence emission spectra of Fas TMD (0.35 mol %
of the total lipid) incorporated in liposomes made of
POPC/PSM/Chol 72:23:5 (single ld phase) and 25:35:40
mol/mol/mol (single lo phase) (Fig. S1) MLVs are shownBiophysical Journal 101(7) 1632–1641
1634 Castro et al.in Fig. 1 A. The photophysical data acquired result from
the simultaneous excitation of the two Trp residues in
Fas TMD and therefore correspond to the combined emis-
sion of Trp176 and Trp189. However, since they are symmet-
rically located, close to the opposite extremes of the helix,
identical environments are being reported. The spectral
position is sensitive to the lipid phase: in the ld phase,
the emission maximum occurs near l ¼ 330 nm; in the
lo phase, it is shifted to l ¼ 340 nm. The significantly
blue-shifted emission obtained in ld liposomes contrasts
with Trp emission in an aqueous environment (l ¼
350 nm (31); Dl ¼ 20 nm), clearly showing that Fas
TMD tryptophan residues are in a predominantly non-
water-solvating environment. In lo membranes, the less
blue-shifted emission (Dl ¼ 10 nm relative to water) shows
that Fas Trp are less protected from the aqueous solvent. In
both cases, the peptide is membrane-bound, since after
centrifugation of Fas TMD-containing liposomes in either
pure ld or lo phases, Fas TMD was not detected in the
aqueous supernatant (data not shown), as expected for theFIGURE 1 Fas TMD steady-state fluorescence (simultaneous excitation
of Trp176 and Trp189). (A) Normalized and corrected fluorescence emission
spectra of Fas TMD (0.35 mol % of total lipid) in POPC/PSM/Chol
membranes in ld (black) and lo (gray) phases. (B) Steady-state fluorescence
anisotropy (hri) of Fas TMD in POPC/PSM/Chol liposomes as a function of
Xlo. The data were acquired at room temperature, with lexc ¼ 280 nm and
lem ¼ 340 nm, and the peptide concentrations were 0.35 mol % (solid
circles), 0.7 mol % (gray circles), and 3.0 mol % (open circles) relative
to the total lipid. The dashed lines are merely a guide to the eye. The error
bars represent the standard deviations of at least three independent samples.
Biophysical Journal 101(7) 1632–1641quite hydrophobic a-helical transmembrane segment of
Fas (3,4).
Fas TMD steady-state fluorescence anisotropy data
(Fig. 1 B) show that the peptide has different mobility in
ld-rich and lo-rich membranes. For liposomes in a pure ld
phase or with low Xlo, the values are higher, showing that
the peptide is fairly immobile. A similar anisotropy value
(~0.09) was obtained by us in a previous study of a Trp-con-
taining peptide strongly immobilized in membranes (30).
Increasing Xlo, the steady-state anisotropy of Fas TMD de-
creases, reaching a value of ~0.06 in liposomes in a pure
lo phase. In these membranes, the peptide induced an exten-
sive aggregation of the liposomes perceptible by the in-
creased turbidity of the samples (not shown), as reflected
by the higher experimental error values obtained (Fig. 1 B).
The lower fluorescence anisotropy values obtained for Fas
TMD in lo-rich membranes is somewhat surprising. It might
be expected that a transmembrane peptide would present
higher fluorescence anisotropy values in lo than in ld
membranes, due to the higher order and less flexibility of
the lo phase (26). Each peptide molecule contains two Trp
residues, but emission depolarization by intrapeptide energy
homotransfer is negligible. The distance separating the two
Trp residues is 18 A˚ (assuming an ideal transmembrane
a-helix), which is nearly two times larger than the critical
radius (R0) for energy homotransfer between Trp residues
(10 A˚) (27). The lower steady-state anisotropy and less
blue-shifted emission of Fas TMD in lo-rich membranes
suggests that the peptide is more flexible and less protected
from the aqueous solvent than in ld-rich membranes. None-
theless, other processes could be responsible for the lower
steady-state anisotropy of Fas TMD measured in the lo
phase. For example, a variation of the Fas TMD fluores-
cence lifetime would affect Trp steady-state anisotropy,
though we will show later that this is not the case. An alter-
native cause, in the case of peptide aggregate formation,
could be emission depolarization due to interpeptide energy
homotransfer.
To investigate the lateral distribution of the peptide, a study
of the effect of Fas TMD concentration on its steady-state
fluorescence anisotropy was carried out (Fig. 1 B). Doubling
Fas TMD concentration to 0.7 mol % (relative to the total
lipid) did not result in significant changes of the steady-state
fluorescence anisotropy values. Only for 3.0 mol % of
peptide was a perceptible decrease in Fas TMD steady-state
anisotropy obtained in all mixtures studied. This suggests
that for the highest Fas TMD concentration, emission depo-
larization by an intermolecular energy homotransfer might
be occurring. At a peptide concentration as high as this, emis-
sion depolarization by energy homotransfer is expected to
occur even for a random distribution of peptide (27). The
fact that there are no significant changes between 0.35 and
0.7 mol % suggests that these concentrations of peptide are
sufficiently low to consider an infinite-dilution regime.
Nevertheless, it still could be speculated that Fas TMD low
Fas Transmembrane Domain Organization 1635steady-state fluorescence anisotropy in lo-rich liposomes
results from an efficient energy homotransfer process due
to peptide aggregation in this phase. However, this hypoth-
esis can be ruled out, as shown later.
Since Fas TMD emission and steady-state anisotropy sug-
gest that the peptide has different solvent exposure and
mobility in ld and lo-rich membranes, studies of Trp fluores-
cence quenching by the aqueous quencher acrylamide were
performed to further investigate Fas TMD membrane orga-
nization (Fig. S2 and text in the Supporting Material). The
bimolecular rate constant of the quenching process, kQ
(Eqs. S1 and S2), recovered for Fas Trp in lo-rich liposomes
(kQ¼ 1.24 109 M1 s1) is higher than the value obtained
for the ld phase (kQ ¼ 3.83  108 M1 s1). This clearly
shows that the accessibility of acrylamide to Fas Trp is
higher in the lo than in the ld phase. This is in agreement
with Fas TMD lower steady-state anisotropy and less
blue-shifted emission in the lo phase, showing that the
peptide is in fact more flexible and less protected from the
aqueous solvent in this phase compared to the ld phase.Fas TMD fluorescence lifetime and preference
for the ld phase
To obtain more detailed information about Fas TMD
aggregation and conformation in the different lipid phases,
time-resolved fluorescence measurements, namely, Trp
fluorescence lifetimes and time-resolved anisotropy, were
also conducted.
The quantum-yield-weighted lifetime (Eq. 2) of Fas TMD
in POPC/PSM/Chol membranes is presented in Fig. 2 as a
function of the lo-phase molar fraction (Xlo). Trp fluores-FIGURE 2 Fas TMD quantum-yield-weighted lifetimes as a function of
Xlo in POPC/PSM/Chol membranes at room temperature with lexc ¼
295 nm and lem ¼ 340 nm. The peptide concentration was 0.35 mol %
(solid circles), 0.70 mol % (gray circles), and 3.0 mol % (open circles)
of total lipid. The dashed lines serve as a guide to the eye. The error bars
represent the standard deviations corresponding to at least three indepen-
dent samples.(Inset) Nonlinear fit of Eq. 4 to the experimental data for
0.35 mol % peptide (from Fig. 2), with K
lo=ld
p ¼ 0.24 5 0.02 (R2 ¼
0.998), where K
lo=ld
p is the Fas TMD partition coefficient between the lo
and ld phases in POPC/PSM/Chol membranes at room temperature.cence decays are described by the sum of three exponentials
(reduced c2 % 1.2). The peptide quantum-yield-weighted
lifetime presents the same trend as the steady-state fluores-
cence anisotropy (Fig. 1 B). In ld-rich membranes, Trp
quantum-yield-weighted lifetimes ðtÞ are high and decrease
with increase of the Xlo. Increasing Fas TMD concentration
to 0.7 mol % did not induce significant changes in Trp
quantum-yield-weighted lifetimes, but when the concentra-
tion reached 3.0 mol %, Trp lifetimes became shorter for the
membrane compositions with Xlo < 0.8 (Fig. 2). This
decrease in Trp lifetimes for 3.0 mol % Fas can be ascribed
to the presence of Cys and Lys residues in Fas TMD, which
are known to be efficient quenchers of Trp fluorescence
(32). At this high peptide concentration, an intermolecular
dynamic self-quenching process is operative, reducing the
Trp fluorescence emission lifetime.
On the other hand, the influence of thefluorescence lifetime
on the steady-state anisotropy should be discussed.According
to Perrin’s equation (r ¼ r0=1þ t
f
; see, e.g., Lakowicz (31)),
a decrease in Trp fluorescence lifetime should lead to an
increase in Trp steady-state fluorescence anisotropy. This is
not the case for Fas TMD, since both the peptide fluorescence
lifetime and steady-state anisotropy decrease when Xlo
increases (Figs. 1 B and 2). Fas TMD steady-state anisotropy,
emission spectra, and time-resolved fluorescence intensity
data suggest that the peptide has a different membrane orga-
nization in the ld and lo phases. It is likely that the peptide
changes from a transmembrane conformation in the ld phase
to a nontransmembrane state in the lo phase.
Membrane composition affects peptide organization, and
Fas TMD may also affect the membrane properties of the
POPC/PSM/Chol mixtures. Thus, experiments were per-
formed to evaluate Fas TMD effects on the lipid phase coex-
istence and the lipid domain size of these ternary mixtures
(Supporting Material). It was found that Fas TMD does
not affect the overall properties of the membrane at the
hydrophobic core level, as reported by t-PnA fluorescence
lifetime (Fig. S3 A). The fluorescence lifetime of t-PnA is
very sensitive to alterations in the fraction and composition
of the ordered domains, and its invariance in the absence and
presence of 0.35 mol % Fas TMD shows that the phase-
coexistence region of the POPC/PSM/Chol phase diagram
is not affected by the presence of Fas TMD. However, the
size of the lipid domains formed in these ternary lipid
mixtures is affected by the presence of the peptide, as
seen by the FRET efficiency between NBD-DPPE and
Rho-DOPE (Fig. S3 B). In the presence of Fas TMD, the
lower FRET efficiencies measured show that the domains
formed are larger and also suggest that for membranes
with high Xlo, Fas TMD might increase the membrane
surface area (Supporting Material). Since the POPC/PSM/
Chol phase-coexistence region is not changed by the pres-
ence of peptide, it is possible to determine the Fas TMD
partition coefficient between the lo and ld phases ðKlo=ldp ÞBiophysical Journal 101(7) 1632–1641
TABLE 1 Time-resolved fluorescence anisotropy parameters
of Fas TMD in ld and lo-rich vesicles
Xlo hriexp f1 (ns) b1 f2 (ns) b2 rN c2 hricalc
0 0.0905 0.006 0.033 0.067 4.325 0.045 0.064 1.098 0.088
0.86 0.0615 0.005 —* —* 0.861 0.021 0.055 1.145 0.061
1636 Castro et al.from the fit of Eq. 4 to the quantum-yield-weighted lifetime
variation of Fas Trp with Xlo for mixtures with 0.35 mol %
of peptide (Fig. 2, inset). The value of K
lo=ld
p ¼ 0.245 0.02
obtained states that Fas TMD has a strong preferential parti-
tion toward the ld phase.Parameters include rotational correlation times, fi, amplitudes, bi, and
limiting anisotropy, rN. Vesicles with Xlo ¼ 0 are ld and those with Xlo ¼
0.86 are lo-rich; measurements were made at room temperature. Also
shown are the experimentally measured steady-state fluorescence anisot-
ropy, hriexp, and the steady-state anisotropy value calculated from the inte-
gration of the anisotropy decay, hricalc. Peptide concentration was 0.35 mol
% relative to total lipid.
*In lo-rich membranes, Fas TMD anisotropy decays were described by
single-correlation rotational time (see text for further details).Time-resolved fluorescence anisotropy:
Fas TMD membrane dynamics
Time-resolved fluorescence anisotropy decays for Fas TMD
in ld-rich and lo-rich membranes were also obtained (Fig. 3).
Table 1 presents the parameters describing those decays ac-
cording to Eq. 3. In ld membranes, the observed Fas TMD
anisotropy decays were well described by two rotational
correlation times (f1 and f2) with similar contributions and
a limiting (residual) nonzero anisotropy. The residual anisot-
ropy reflects the maximum degree of mobility of Fas TMD in
the membrane (31). In lo-rich membranes, Fas TMD anisot-
ropy decays were described by only one rotational correla-
tion time (f1) and a lower residual anisotropy (Fig. 3 and
Table 1). For pure lo membranes, high-quality data could
not be obtained due to the Fas-TMD-induced liposome
aggregation mentioned previously, and for that reason, the
data were acquired for the lipid mixture corresponding to
Xlo ¼ 0.86. Good agreement was obtained between the
steady-state anisotropy values calculated from the integratedFIGURE 3 Time-resolved fluorescence anisotropy (r(t)) of Fas TMD
(Trp176 and Trp189) incorporated in ld (solid circles) and lo-rich (Xlo ¼
0.86) (open circles) POPC/PSM/Chol membranes, obtained at room
temperature with lexc ¼ 295 nm and lem ¼ 340 nm. (Upper) Circles are
the experimental data points, and solid lines are the corresponding fits of
Eq. 3. (Lower) Weighted residuals of each fit. The fitting parameters are
shown in Table 1. Peptide concentration was 0.35 mol % total lipid.
Biophysical Journal 101(7) 1632–1641anisotropy decay and the experimentally determined values,
both for lo-rich and ld membranes (Table 1). In both mem-
brane types, the limiting anisotropy makes a large contribu-
tion to the peptide total anisotropy, reflecting Fas TMD
association with the lipid membrane. However, the lower
residual anisotropy value recovered for Fas TMD in lo-rich
membranes, as compared with ld membranes, shows that
Fas Trp has a higher degree of wobbling in lo-rich liposomes.
Note that in the lipid mixture with Xlo¼ 0.86, more than half
of the emission light (~60%) arises from peptide molecules
located in the residual ld phase as a result of Fas TMD higher
partition and quantum yield in ld domains. Therefore, Fas
TMD residual anisotropy in pure lo membranes should be
even lower. The estimated residual anisotropy of 0.043 for
pure lo membranes clearly reflects the less constricted con-
figuration of Fas TMD in the lo phase compared to the ld
phase. These results, together with the absence of a long
correlation rotational time in Fas TMD anisotropy decay
measured in these membranes, clearly show that the peptide
has a different organization in the lo and ld phases, being less
constrained in the lo phase. In this latter phase, Fas TMD is
indeed in a nontransmembrane state as indicated by the
previous fluorescence data.ATR-FTIR measurements: Fas TMD membrane
conformation
To gain further knowledge about Fas TMD membrane orga-
nization, ATR-FTIR studies were also performed. From
these measurements, information about Fas TMD mem-
brane orientation can be obtained. In Fig. 4 A are presented
dichroic ATR-FTIR spectra for Fas TMD in ld and lo-rich
membranes. The negative deviations observed in all spectra
around 2850 cm1 and 2920 cm1 correspond to the lipid
ns(CH2) and nas(CH2) signals (stretching), respectively, re-
flecting the parallel orientation of the lipid acyl chain to
the bilayer normal. In other words, the expected parallel
orientation of the lipid multilayer to the germanium crystal
surface was successfully achieved (33,34). The positive
deviations obtained around 1650 cm1 and 1550 cm1
correspond to the peptide amide I and amide II bands and
FIGURE 4 (A) Dichroic ATR-FTIR spectra of Fas TMD-POPC/PSM/
Chol membranes in the ld, lo-rich (Xlo ¼ 0.86), and lo phases. (B) Dichroic
spectra rescaled to the amide I and amide II regions. The spectra are shifted
along the ordinate for a better reading.
FIGURE 5 Ceramide has minor effects on Fas TMD membrane organi-
Fas Transmembrane Domain Organization 1637reflect the contribution of Fas TMD to the infrared signal. The
rescaled spectra in this region are presented in Fig. 4 B. For ld
membranes (bottom line), the amide I signal has a maximum
around 1652 cm1, clearly showing that Fas TMD has
a predominant transmembrane a-helical conformation
(33,34). For lo-rich (Xlo¼ 0.86) and lo (Xlo¼ 1) membranes,
the amide I signal is shifted to higher wavenumbers, with
a maximum around 1680 cm1. This shows that the peptide
is in a nonhelical structure, although the main conformation
cannot be precisely defined. It is possible that the lower
stability of Fas TMD in these membranes results in a peptide
population with different conformations that can be short
helices, stressed helices, or turns. It is worth mentioning
that b-sheet formation was not detected in the ATR spectra
of any of thesemembranes, indicating that peptide aggregates
are not forming. Altogether, the infrared results shows that in
ld membranes Fas TMD adopts an a-helical transmembrane
conformation (as expected for a TMD of a membrane
protein), whereas in lo membranes, the peptide is in a non-
transmembrane state, as supported by the fluorescence data.zation. (A) Steady-state fluorescence anisotropy (hri) of Fas TMD in
POPC/PSM/Chol membranes containing 0 (solid circles), 2 (gray circles),
and 4 (open circles) mol % PCer. (Inset) Fas peptide steady-state anisotropy
values in membranes containing PCer calculated assuming no alterations in
the fluorescence lifetime. (B) Quantum-yield-weighted lifetimes ðtÞ of Fas
TMD in the membranes in A. Errors bars represent standard deviations of at
least three independent samples.Effect of ceramide on Fas TMD membrane
organization
To investigate Cer effects on Fas plasma membrane organi-
zation, Fas peptide steady-state fluorescence anisotropy andfluorescence lifetimes were measured in POPC/PSM/Chol
membranes with 2 mol % and 4 mol % PCer (Fig. 5). In
membranes with Cer, Fas TMD steady-state anisotropy
and quantum-yield-weighted lifetimes present the same
trend of variation as in liposomes with no PCer. At first
glance, PCer seems to affect both Fas Trp quantum-yield-
weighted lifetimes and rotational dynamics. For a membrane
with a given composition, the presence of PCer decreases
Fas TMD steady-state anisotropy and increases its fluores-
cence lifetime. For instance, in the absence of PCer, and
in membranes with Xlo ¼ 0.26, Fas TMD has a steady-state
fluorescence anisotropy of 0.0935 0.005 and a fluorescence
lifetime of 3.50 5 0.12 ns. For membranes with the same
composition but containing 2 mol % PCer, those values
are 0.080 5 0.003 and 3.92 5 0.02 ns, respectively.
When a modified Perrin equation, which takes into account
the limiting anisotropy contribution, is used to correct Fas
TMD steady-state fluorescence anisotropy for the increase
in peptide lifetimes, a value of 0.093 is obtained (r0 ¼
0.270 (35)). Calculating all values of Fas TMD steady-state
anisotropy that would be obtained hypothetically if there
were no changes in the fluorescence lifetime in membranesBiophysical Journal 101(7) 1632–1641
1638 Castro et al.with Cer resulted in anisotropy values similar to those ob-
tained in membranes without Cer (Fig. 4 A, inset). This
shows that PCer does not affect Fas TMD steady-state
anisotropy, but slightly increases its fluorescence lifetimes.DISCUSSION
Fas TMD membrane organization and dynamics
In this work, we have exploited the intrinsic fluorescence of
the two tryptophan residues (Trp176 and Trp189) of Fas TMD
reconstituted into POPC/PSM/Chol (raft model) membranes
with or without Cer, to better understand how lipid rafts and
Cer modulate Fas conformation and membrane lateral
distribution. Further evidence regarding peptide structure
and organization was obtained from ATR-FTIR. In vivo,
Fas is expressed in plasma membrane as preassembled
trimers (1,2). Fas trimerization is maintained mainly by
interactions between each extracellular (via the preligand
receptor association domain (PLAD)) and intracellular
domains (by the death domains of Fas and FADD) (2,4).
TMD interactions are unlikely to occur, since they are
hindered by the bulkier ecto and endodomains of the
receptor and therefore play a minor role in Fas association.
In this study, the absence of intermolecular static-quenching
(data not shown), which could be a likely process in the case
of dimer (or trimer) formation, shows that Fas TMD does
not aggregate. This is also supported by the ATR-FTIR
data. Only for the highest Fas concentration studied
(3 mol %) was a small extent of interaction detected. This
is shown by Trp lower quantum-yield-weighted lifetimes
in ld-rich membranes when compared to diluted samples
(Fig. 2), which can be interpreted as a result of a dynamic
self-quenching process. The effect of collisional self-
quenching on the fluorescence lifetime of a molecule with a
complex decay and its relation with the diffusion coefficient
(D) is shown in the Supporting Material (Eqs. S9–S11).
Assuming a random peptide distribution in the membrane,
a value of D ¼ 11  109 cm2 s1 is obtained. This value
is in the same order of magnitude of those typically found
for TMD protein diffusion in an ld phase (D ¼ 10–70 
109 cm2 s1 (27,36,37)), showing that Fas TMD does not
exhibit significant aggregation in these membranes, being
mostly monomeric and hence in a similar configuration as
in vivo.
Our results show that the membrane state modulates Fas
TMD organization. In ld-rich membranes, Fas TMD is in a
transmembrane a-helical conformation with a severely re-
stricted rotational dynamics and a lateral diffusion typical
of the ld phase. In lo-rich membranes, Fas TMD is likely
located near the membrane-water interface, where its Trps
are more exposed to the aqueous solvent and much less con-
strained. As a result, compared to the case for ld mem-
branes, Fas Trps present red-shifted emission, shorter
fluorescence lifetimes, and lower steady-state anisotropy.Biophysical Journal 101(7) 1632–1641An alternative explanation for these results is the formation
of transmembrane peptide clusters in the lo phase, which
might lead to efficient fluorescence self-quenching and
energy homotransfer processes. However, our results do
not support this hypothesis. Trp red-shifted emission and
higher accessibility to acrylamide in lo-rich membranes
show that Fas TMD is less protected from water than in ld
membranes. Furthermore, neither a-helical conformation
nor aggregate formation could be detected by ATR-FTIR
for lo-rich membranes (Fig. 4 B). The observation of Fas-
TMD-induced liposome aggregation in lo-rich membranes
also points to a Fas TMD location near the membrane-water
interface, since membrane aggregation mediated by interfa-
cial located hydrophobic peptides is one way of decreasing
hydrophobic residue exposure to the polar solvent (38).
Time-resolved fluorescence anisotropy data (Fig. 3 and
Table 1) also supports the postulated nontransmembrane
state of Fas TMD in the lo phase (Fig. 3 and Table 1). Inde-
pendent of peptide cluster formation, if Fas TMD was
located inside the bilayer in lo-rich membranes, its rota-
tional freedom would be low due to the higher order and
lower flexibility of the lo phase (26). Thus, its anisotropy
decay would be characterized by a high limiting anisotropy,
which should be higher than its limiting anisotropy in ld
membranes. This is not the case, since the peptide residual
anisotropy in the lo phase is lower than in the ld phase. Alto-
gether, these results highlight the nontransmembrane con-
formation of Fas TMD in lo-rich membranes.
In the ld phase, Fas TMD anisotropy decay was described
by two correlation times, f1 and f2 (Table 1). The shorter
correlation time (f1) can be attributed to movements of
the Trp indole ring, and its value is similar to the short corre-
lation times of the Trp-containing TMD of acetylcholine
receptor gM4 inserted into lipid bilayers (30). The peptide
longer correlation time (f2) results from movements
involving several amino acid residues. NH groups of Trp
indole moiety are potentially capable of forming hydrogen
bonds with the hydroxyl groups of surrounding molecules,
drastically decreasing molecular rotation (39). In ld mem-
branes, Fas-TMD-hindered rotations, reflected by its high
limiting anisotropy, indicate that its Trp residues have strong
interactions with the lipid. This is in accordance with the re-
maining fluorescence (blue-shifted emission, less fluores-
cence quenching by acrylamide, and long fluorescence
lifetimes) and infrared data (a-helical signal in ATR
spectra), which already suggested that Fas Trp would be
in a hydrophobic environment.Lipid rafts, ceramide, and Fas TMD membrane
lateral distribution
Fas recruitment to lipid rafts, where it aggregates with other
Fas receptors and other proteins (FADD and procaspase-8),
is a crucial step of apoptotic signaling (5–8). Our results
demonstrate that Fas TMD plays a minor role in receptor
Fas Transmembrane Domain Organization 1639translocation to lipid rafts. In addition, it does not induce
alterations in the POPC/PSM/Chol phase diagram (Fig. S3).
The peptide partition coefficient between raft and non-
raft regions (K
lo=ld
p ¼ 0.24 5 0.02) (Fig. 2, inset) shows
that the Fas TMD concentration is around four times higher
in the ld (nonraft) phase than in the lo (raft) phase. The
in vivo translocation of Fas to lipid rafts must therefore
occur by a different process. Studies have shown that native
Fas is palmitoylated at a Cys residue of the cytoplasmatic
region proximal to the membrane, and this posttranslational
modification was identified as the main mechanism local-
izing Fas to lipid rafts (12,13). In this study, the less efficient
localization of Fas TMD to raft regions results from the
absence of palmitoylation and from the strong hydrophobic
mismatch between the peptide and lo bilayers. These mem-
branes have a bilayer thickness of 40 A˚, with a hydrophobic
region of 30 A˚ (42). Being a 21-residue-long hydrophobic
peptide with a-helical structure (3,4), Fas TMD has a total
length of ~32 A˚ and is thus 8 A˚ shorter than lo membranes.
This strong negative hydrophobic mismatch is responsible
for Fas TMD avoiding lo domains and for the conforma-
tional change detected for lo-rich membranes. In this case,
the free energy for Fas TMD insertion into the thick lo
bilayer is much higher than the entropy-driven forces that
minimize the hydrogen-bonding network reorganization of
water caused by unfavorable interactions of Fas TMD
hydrophobic residues with polar water molecules (hydro-
phobic effect). As a result, Fas TMD adopts a nontransmem-
brane conformation and probably translocates to a position
near the membrane surface. This is not expected to occur
in vivo since the transmembrane state of TMD will be stabi-
lized by the bulkier charged exo- and cytoplasmatic
domains of the receptor. On the other hand, ld membranes
have a thickness of 36 A˚, with a hydrophobic region of
26 A˚ (42). Between Fas TMD and ld bilayers there is only
a slight negative hydrophobic mismatch (~4 A˚) that is not
strong enough to drive the peptide from a transmembrane
conformation to a nontransmembrane state. Therefore, in
a situation where there is ld-lo phase separation, similar
to plasma membrane rafts (nonpalmitoylated) in cells,
Fas TMD higher preference for the thinner/disordered
membranes will drive the receptor to those membrane
regions.
It has been reported that Cer drives the fusion of small
rafts into large signaling platforms, facilitating Fas clus-
tering and thus improving Fas signaling (14,15). Although
studies in model systems have shown that Cer is not able
to induce the formation of large domains (22,23), doubt
remains about the ability of this lipid to change Fas mem-
brane localization and organization. Our results show that
Cer does not affect Fas TMD membrane organization but
does increase Fas Trp fluorescence lifetimes. This reflects
the increased compactness of membranes containing Cer
(18–20). Furthermore, Fas TMD fluorescence parameters
in mixtures containing Cer-rich gel (4 mol % PCer, Xlo %0.58 (23)) are essentially the same as for those in which
no gel is formed (2 mol % PCer) (23) (Fig. 5), showing
that the peptide conformation and lateral distribution are
not affected by the formation of Cer-rich gel. These results
are in accordance with a previous study that shows that in
the absence of any death stimuli, Cer cannot induce Fas
translocation to lipid rafts (8). By increasing membrane
order, Cer reduces the lateral diffusion of membrane
proteins and lipids, trapping and clustering those molecules
(25). In lipid rafts with Cer, Fas oligomer diffusion will be
reduced, minimizing complex dissociation and receptor
translocation out of those regions. As a result, formation
of large and stable apoptotic protein clusters is enhanced,
resulting in efficient triggering of apoptosis. This seems to
be the general mechanism by which Cer traps and clusters
raft-associated proteins and lipids, namely Fcg receptor II
(43,44), CD40 (45), GPI-PLAP and ganglioside GM1 (25),
and Fas (14,15). Therefore, Cer is apparently not involved
in Fas trimer recruitment to lipid rafts, but enhances Fas
clustering with other Fas trimers and other proteins of the
apoptotic machinery in those membrane domains.Implications for Fas-mediated cell death
To trigger apoptosis, Fas needs to oligomerize and cluster
with intracellular apoptotic proteins to activate the apical
protease caspase-8 (1,2). However, these processes only
occur after Fas translocation into lipid rafts, where the
apoptotic proteins are concentrated (5–7), making this
process the central step of Fas early (membrane) signaling
events (1,2). Our results suggest that Fas TMD does not
participate in receptor translocation into lipid rafts. In fact,
our results show that Fas TMD has a marked preference
toward nonraft regions. This feature of the Fas receptor
may correspond to a protective mechanism of cells against
apoptosis triggering in the absence of death stimuli. Fas
has an intrinsic ability to cocluster (either by its extracellular
PLAD domain or by its cytoplasmatic death domain (4)) and
starts apoptosis in the absence of its ligand (FasL) and even
without an intact extracellular domain (46). To overcome
the natural facility of Fas to cap, the protein is equipped
with a TMD that has a low ability to localize into membrane
regions where the probability of apoptosis triggering by
receptor oligomerization is enhanced. This hypothesis is
supported by studies that show that Fas needs to be palmi-
toylated to translocate into lipid rafts (12,13), and it has
been suggested that the regulation of Fas palmitoylation
determines protein localization into or out of rafts (4,11).
Moreover, differences in Fas palmitoylation were thought
to be responsible for the constitutive presence of Fas in lipid
rafts of some cells (type I), whereas in most resting cells
(type II), Fas is excluded from those regions (4,11). Thus,
it seems that in the absence of death stimuli, the proapop-
totic attribute of Fas to cluster with cell death machinery
proteins located in lipid rafts is hampered by its lowBiophysical Journal 101(7) 1632–1641
1640 Castro et al.partition to those membrane regions, which results from
the lack of palmitoylation and the short length of the Fas
TMD.
Altogether, this study highlights the role of Fas TMD as
a regulator of Fas translocation to lipid rafts, the main stage
of Fas signaling early events. The TMD of Fas strongly
stalls receptor localization into lipid rafts, suggesting that
its length and sequence may have a protective role against
unspecific Fas-mediated apoptosis.SUPPORTING MATERIAL
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